Literature DB >> 17392309

Idiopathic pulmonary fibrosis--new insights.

Subodh Verma1, Arthur S Slutsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17392309     DOI： 10.1056/NEJMcibr070490

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Association of TNF-α-308(G/A) and -238(G/A) polymorphisms with non-traumatic osteonecrosis of the femoral head risks: a meta-analysis.

Authors:  Yizhong Peng; Yuenan Liu; Donghua Huang; Wei Huang; Zengwu Shao
Journal:  Int Orthop       Date:  2018-03-07       Impact factor: 3.075

2.  A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset.

Authors:  Marcella Martinelli; Angela Maria Grazia Pacilli; Stefano Rivetti; Mattia Lauriola; Luca Fasano; Paolo Carbonara; Gabriella Mattei; Ilaria Valentini; Luca Scapoli; Rossella Solmi
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

Review 3.  Caveolins and lung function.

Authors:  Nikolaos A Maniatis; Olga Chernaya; Vasily Shinin; Richard D Minshall
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts.

Authors:  Li-jun Chen; Wan-de Li; Shi-feng Li; Xing-wen Su; Guang-yun Lin; Yi-jun Huang; Guang-mei Yan
Journal:  Acta Pharmacol Sin       Date:  2010-04-26       Impact factor: 6.150

Review 5.  Caveolin-3 regulates myostatin signaling. Mini-review.

Authors:  Y Ohsawa; T Okada; A Kuga; S Hayashi; T Murakami; K Tsuchida; S Noji; Y Sunada
Journal:  Acta Myol       Date:  2008-07

Review 6.  Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.

Authors:  Francesco Del Galdo; Michael P Lisanti; Sergio A Jimenez
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

7.  The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.

Authors:  Haihai Liang; Chaoqian Xu; Zhenwei Pan; Ying Zhang; Zhidan Xu; Yingzhun Chen; Tianyu Li; Xuelian Li; Ying Liu; Longtao Huangfu; Ying Lu; Zhihua Zhang; Baofeng Yang; Samuel Gitau; Yanjie Lu; Hongli Shan; Zhimin Du
Journal:  Mol Ther       Date:  2014-03-05       Impact factor: 11.454

8.  Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians.

Authors:  Gil Atzmon; Miook Cho; Richard M Cawthon; Temuri Budagov; Micol Katz; Xiaoman Yang; Glenn Siegel; Aviv Bergman; Derek M Huffman; Clyde B Schechter; Woodring E Wright; Jerry W Shay; Nir Barzilai; Diddahally R Govindaraju; Yousin Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

9.  Therapeutic effect of lung mixed culture-derived epithelial cells on lung fibrosis.

Authors:  Kensuke Tanaka; Tetsuo Fujita; Hiroki Umezawa; Kana Namiki; Kento Yoshioka; Masahiko Hagihara; Tatsuhiko Sudo; Sadao Kimura; Koichiro Tatsumi; Yoshitoshi Kasuya
Journal:  Lab Invest       Date:  2014-09-08       Impact factor: 5.662

10.  A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.

Authors:  Claude Jourdan Le Saux; Philip Davy; Christopher Brampton; Seema S Ahuja; Steven Fauce; Pooja Shivshankar; Hieu Nguyen; Mahesh Ramaseshan; Robert Tressler; Zhu Pirot; Calvin B Harley; Richard Allsopp
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.